Brevan Howard Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.1M Buy
101,388
+87,082
+609% +$18.1M 0.18% 87
2026
Q1
$3.02M Sell
14,306
-534
-4% -$115K 0.03% 407
2025
Q4
$3.05M Buy
14,840
+140
+1% +$26.3K 0.03% 346
2025
Q3
$2.31M Sell
14,700
-36,556
-71% -$5.65M 0.01% 497
2025
Q2
$8.61M Buy
+51,256
New +$7.61M 0.05% 219
2025
Q1
Sell
-8,981
Closed -$1.06M 1183
2024
Q4
$1.06M Sell
8,981
-26,700
-75% -$3.12M 0.01% 416
2024
Q3
$3.94M Buy
35,681
+27,151
+318% +$2.84M 0.03% 156
2024
Q2
$839K Buy
8,530
+5,638
+195% +$575K 0.01% 433
2024
Q1
$324K Sell
2,892
-7,199
-71% -$777K ﹤0.01% 624
2023
Q4
$1.02M Buy
+10,091
New +$1M 0.01% 231

Other funds holding CAH

Brevan Howard Capital Management's CAH Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Cardinal Health (CAH) stake by 609% in Q2 2026, buying an estimated $18.1M and bringing the position to 101,388 shares worth $24.1M. The position accounts for 0.18% of the portfolio, ranked #87.

Brevan Howard Capital Management first reported a position in CAH in Q4 2023 and has held it in 10 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Brevan Howard Capital Management held 101,388 shares of Cardinal Health worth $24.1M as of Q2 2026.
  • Brevan Howard Capital Management bought 87,082 Cardinal Health shares in Q2 2026, an estimated $18.1M.
  • Cardinal Health made up 0.18% of Brevan Howard Capital Management's portfolio in Q2 2026, its #87 holding.
  • Brevan Howard Capital Management first reported a position in Cardinal Health in Q4 2023 and has held it in 10 quarters since.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.